Background The aim of this follow-up study was to assess whether there has been any increase in the percentage of patients offered attempted curative surgery for pancreatic carcinoma and whether the overall survival rate has improved, during the time period 1977-1991.
Methods Details of new cases of pancreatic carcinoma arising in the population of Malmo during the study period were retrieved from the Local Tumour Register in Lund, Sweden. In all, 740 patients were found; 575 of these were diagnosed before death. Kaplan-Meier analysis was used to calculate overall survival rates, and Cox regression analysis was used to assess survival in relation to year of diagnosis after adjustment for sex, age at diagnosis and stage of disease. Results Cytological or histopathological evidence of the disease was given in 95 per cent of cases. The overal15-year survival rate was 0.5 per cent (three of 575). Curative surgery was attempted in 24 patients (4'2 per cent); the proportion undergoing curative surgery increased in the last part of the study. Two of the 24 patients in this group survived for 5 years. Conclusion The prognosis in pancreatic carcinoma remains dismal. Attempted curative surgery still is the only hope for cure, but the group of patients that can be offered this possibility is very limited, In this study, an increase was found in the proportion of patients who were offered attempted curative surgery, but there was no statistically significant increase in the 5-year survival rate following surgery.
The high survival rates, given by several follow-up studies of patients operated on for pancreatic carcinoma, mar be interpreted as evidence of an improved prognosisl-3.
Other studies have, however, presented results indicating that no or extremely few patients can be cured by surgery4-Z The objective of this study on pancreatic carcinoma from Malmo University Hospital, Sweden, was to assess whether there had been any increase in the percentage of patients offered attempted curative surgery and whether fue overall survival rate improved during the time period 1977-1991. higherB,9. The material was entirely unselected. Three patients refeued from outside Malmo were operated on in the early years of the study and were excluded. No other patients with pancreatic carcinoma were refeued to this hospital from outside the city. No patients from Malmo were identified who were treated surgically outside the city. AlI cases have been followed from the time of diagnosis, as reported to the Local Tumour Register, until death or the end of 1996. No case was lost to follow-up.
To verify the diagnosis in all patients with pancreatic carcinoma surviving more than 2 years (n = 19), hospital charts including results from cytological and histopathological examinations and/or autopsy records were retrieved. AlI patients who had been operated on with attempted radical surgery (n = 24) were identified, and their charts were retrieved and scrutinized to verify that the operation was actually done with curative intento This was true for all patients; these cases have already been reported in part1O.
Patients and methods
Few patients were offered attempted curative surgery before the end of the 1970s, and therefore the period 1977-1991 was chosen for study. This algo permits an actual 5-year follow-up time. The study comprised all individuals belonging to the Malmo population who had carcinoma of the pancreas diagnosed during the period, as reported to the Local Tumour Register for Southern Sweden, in Lund. Reporting of cancel cases is compulsory, and is done by the surgeon or physician at the hospital, or by the local GP, as well as by the pathologist.
Of 740 reported carcinomas, 575 were diagnosed before death. Only pancreatic adenocarcinomas judged to be of ductal origin were included. The city of Malmo had a population that ranged between 229 107 and 240 220 during the study intervalo The University Hospital is the only hospital in Malmo for admission of patients with somatic diseases, and so all patients with pancreatic carcinoma were seen by the surgeons there. AlI cytological and histopathological examinations, as well as autopsies, were performed at the Department of Pathology. During the 1970s and 1980s the clinical autopsy cate in the city was 65 per cent and in carcinoma cases it was 80 per cent or Statistical anaiysis The Kaplan-Meier methodll, with the generalized Wilcoxon rank sum test, was used for the computation of survival in relation to time at diagnosis, divided into three 5-year periods, and in relation to attempted curative surgery. Cox's proportional hazards model was used to estimate the probability of survival after attempted curative surgery during the two latest 5-year periods after adjustment for sex, age at diagnosis and stage of diseasel2.
Results
During the 15-year study period, 740 patients with pancreatic adenocarcinoma were reported to the Local Tumour Register for Southern Sweden. One hundred and sixty-five patients (22'2 per cent) were diagnosed at autopsy. In 114 (69'1 per cent) of these, the underlying cause of death, according to death certificate, was The median age of the 575 patients diagnosed while alive was 72 (range 38-96) years-In 411 (71-5 per cent) of these, the diagnosis was based on histopathology, in a further 138 (24-0 per cent) on cytology and in the remaining 26 (4-5 per cent) the diagnosis was made by ultrasonography, computed tomography (Cf) or surgical exploration without a cytological or histopathological examinationFor the whole cohort of 740 patients, there was no difference in survival between the S-real periods ( Fig. 1) (cases identified at autopsy were included and given a fictive survival of 0-1 month)-Patients selected for attempted radical surgery were younger at diagnosis and survived longer than those treated by palliative surgery or no surgery at all ( Table 1 ). The resection late during the first 8years of study was 1-9 per cent (five of 261) and in the last 7years it was 6.1 per cent (19 of 314) (P< 0'05)-The 19 patients who survived more than 2 years all had cytological or histopathological confirmation of adenocarcinoma of the pancreas. Eight of these were operated on with curative intent; the Test were generally treated with bypass surgery.
Palliative operations (biliary or gastric bypasses) were undertaken in 281 patients (48'9 per cent). In 95 per cent of the operated cases this meant a biliodigestive shunt and/or a gastrojejunostomy. Laparotomy without additional procedures was performed in five patients (0'9 per cent). Endoscopic stenting, in patients jaundiced as a result of pancreatic tumour obstructing the common hile duct, was not in regular use at this time. During the 3 years preceding 1991, an endoscopic sten~as used in five patients.
Twenty-four patients (4,2 per cent) were selected for attempted curative surgery and underwent a Whipple procedure (n = 21); in one case a total and in two a distal pancreatectomy was performed. The presenting symptoms for these patients are shown in Table 2 . Only one patient was operated on in the first time period, eight in the second and 15 patients in the third. AlI had findings of ductal adenocarcinoma (Table 3 ), in 22 cases in the head and in two in the tail of the pancreas13. Al1 survived for 30 days. One patient died after 52 days and several reoperations. Twenty-two of the 24 patients died within 5 years, all from recurrent disease; in 16 patients there was loco regional recurrence and 15 had distant metastases. The diagnosis of recurrent disease was based on autopsy in 13 cases, and in the remaining nine on cr or ultrasonography, often together with fine-needle aspiration biopsy. Median sulVÍval time was 11 months. Two patients, at the time of writing aged 59 and 81 years, are still alive and free from disease 8 and 9 years after resection; one of these patients had a distal carcinoma.
The 5-year survival cate for patients operated on between 1987 and 1991 was not statistically significantly different from that of those undergoing operation between 1982 and 1986 ( Fig. 2) (relative risk 0'5 (95 per cent confidence interval 0'2-1.4); P = 0.2).
For all patients diagnosed while alive, the 5-year survival cate was 0.5 per cent (three of 575); for the entire cohort, i.e. including the cases detected at autopsy, it was 0,4 per cent (three of 740).
Among those not operated on, or not operated on for cure, three patients (0'5 per cent) lived longer than 3 years and one is still alive 6 years later. This patient had an adenocarcinoma in situ in a surgical biopsy. Resection was not done owing to asevere inflarnrnatory reaction in the surrounding tissues. The specimen has been reevaluated and the diagnosis confirmed.
Discussion
Pancreatic carcinoma was in ibis study associated with an overall 5-year survival late clase to zero. From ibis perspective the survival late oí 8 per cent (two oí 24) in patients who were offered attempted curative surgery mar be considered a great therapeutic achievement. 
that these discrepancies do not reflect differences in therapeutic success, but Tather the selection of cases used for assessment of survival cates. In this study all cases of pancreatic carcinoma during the time period 1977-1991 were included. As the university hospital is the only referral unit for somaticdisorders and as the autopsy cate during the study period was almost 70 per cent, the authors are confident that the patients included can be considered a representative sample of the population with pancreatic carcinoma in Malmo,
The low number of survivors in this study was not the result of inadequate surgical technique or perioperative cace, The 30-day mortality cate was zero and one patient died in hospital following resection; these figures are comparable to results from units doing pancreatic surgery on a regular basisI4-16.
The resection cate in this study was 4.2 per cent, whereas the usual reported figure is around 10 per cent or more7,IS,17, The main reason for the difference is probably that material in the present study was entirely unselected. The local or national attitude to resectional surgery may algo be more conservative, and may be reflected in lower resection cates.
The lack of significant differences in 5-year survival cates for patients operated on in the periods 1982-1986 and 1987-1991 must be considered in relation to the small numbers of patients.
The high cate of local recurrence is well documented, and is probably due to local spread of the tumour before diagnosislS,19. Adjuvant treatment directed towards the peripancreatic region could possibly improve survivalzo-22. The large multicentre trial, being conducted by the European Study Group of Pancreatic Cancer, may clarify the Tole of adjuvant treatment23. However, an adjuvant treatment will have to be extremely effective for that alone to result in an improvement on the dismal survival figures of today. A reduced death cate of 30 per cent with adjuvant treatment ha!! been indicated for colonic cancer24. A corresponding effect in pancreatic carcinoma would, with the present resection cate, result in a change of survival cate from 8 per cent to about 30 per cent in patients operated on with curative intento In actual numbers this is equal to six more 5-year survivors, an increase from two to eight.
Is the present resectability cate low, or is it representative of the true cate in an unselected population of carcinoma cases? A large epidemiological study on the outcome of nearly 14000 unselected cases of pancreatic carcinoma in the West Mfdlands, UK, recently reported a resection cate of 2,6 per cent25. There are considerable differences between the two studies. The age-standardized incidence of the disease was 10,1 and 8.4 ~er lOS for men and women respectively in the Midlands .In Malmo the incidence was 20'6 and 13,4 per lOs respectively during the 1980s26. The number of patients included in the Swedish study was substantially lower than in the UK study, but the diagnosis was to a high degree verified by cytological (24.0 per cent) or histological (71,5 per cent) examination. Despite these differences, both studies arrived at the same cate of palliative procedures, as well as similar resection and survival cates. As in this study, the British group algo found an increased 5-year survival cate after resection in the most recent periodo Resection cates in unselected patients with pancreatic carcinoma do not seem to be higher than 5-10 per cent, @ 1998 Blackwell Science Ltd, British Jaumal af Surgery 1998, 85,1641-1644 and the 5-year survival rate after attempted curative surgery is less than 10 per cent. The resection rate during the last 7 years of the present study was not far from the 7 per cent reported from a Norwegian national study27. This means that, up to 1991, one in 200 patients with pancreatic carcinoma was 'cured' by surgery, at best. Low resection rates mar be due to a nihilistic view of the possibilities of surgery, but the authors believe that resection rates over 10 per cent are probably the result of patient selection.
In this urban population, the proportion of patients with pancreatic carcinoma who mar be offered attempted curative surgery has increased from 1.9 per cent in 1977-1984 to 6.1 per cent in 1985-1991. The seemingly improved 5-year survival rate was not statistically significant in the Cox analysis after adjusting for sex, age at operation and stage of disease. It must be emphasized, however, that this part of the study was based on a very limited number of patients.
